BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sung M, Chin CH, Lim CG, Liew HS, Lim CS, Kashala E, Weng SJ. What's in the pipeline? Drugs in development for autism spectrum disorder. Neuropsychiatr Dis Treat 2014;10:371-81. [PMID: 24591832 DOI: 10.2147/NDT.S39516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Corominas R, Lin GN. De novo Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application. Front Genet 2019;10:258. [PMID: 31001316 DOI: 10.3389/fgene.2019.00258] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
2 van der Weiden RM, Helmerhorst FM, Eriksson T. Gonadotropin-releasing hormone agonist against severe aggression in autism. BMJ Case Rep 2016;2016:bcr2016216378. [PMID: 27655876 DOI: 10.1136/bcr-2016-216378] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Anashkina AA, Erlykina EI. Molecular Mechanisms of Aberrant Neuroplasticity in Autism Spectrum Disorders (Review). Sovrem Tekhnologii Med 2021;13:78-91. [PMID: 34513070 DOI: 10.17691/stm2021.13.1.10] [Reference Citation Analysis]